Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8669598 | The Journal of Heart and Lung Transplantation | 2018 | 11 Pages |
Abstract
ACHD patients with LVADs have survival similar to non-ACHD patients. Mortality is higher for patients requiring BiVAD/TAH support, potentially owing to higher INTERMACS profile. These outcomes suggest a promising role for LVAD support in ACHD patients as part of the armamentarium of therapies for advanced HF.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christina J. MD, Ari MD, Pirooz MD, PhD, Bryan G. MD, MPH, Jill M. MD, MPH, Luke J. MMBS, PhD, Simon MD, PhD, Devin A. BS, Ryan S. MSPH, Elizabeth D. MD,